申请人:Sumitomo Chemical Company, Limited
公开号:US04228167A1
公开(公告)日:1980-10-14
Novel imidazo[2,1-b]quinazolines and pyrimido-[2,1-b]quinozolines represented by the formula, ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and A are as defined in the specification were prepared. They have prominent pharmacological properties such as diuretic and vasodilating activity.
本发明涉及一种以公式表示的新型咪唑并[2,1-b]喹唑啉和嘧啶并[2,1-b]喹唑啉,其中R1,R2,R3,R4,R5和A如规范中所定义。它们具有显著的药理特性,如利尿和扩血管活性。